BRUKER CORPORATION Business Acquisition, Pro Forma Net Income (Loss)
BRUKER CORPORATION (BRKR) reported Business Acquisition, Pro Forma Net Income (Loss) of -$15.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-02-27
- BRUKER CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2024-12-31 was $0.00.
- BRUKER CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2024-09-30 was $1.80M.
- BRUKER CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2023-12-31 was -$23.40M.
- BRUKER CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2023-09-30 was -$19.00M.
- BRUKER CORPORATION business acquisition, pro forma net income (loss) for fiscal 2024 was -$15.70M.
- BRUKER CORPORATION business acquisition, pro forma net income (loss) for fiscal 2023 was -$88.30M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.80M derived: sum of 2 quarters · filed 2026-02-27 | -$15.70M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.80M 10-Q · filed 2024-11-07 | -$15.70M 10-Q · filed 2024-11-07 | ||
| 2023-12-31 | -$23.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$42.40M derived: sum of 2 quarters · filed 2026-02-27 | -$88.30M 10-K · filed 2026-02-27 | |
| 2023-09-30 | -$19.00M 10-Q · filed 2024-11-07 | -$64.90M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |